Any person may file a new animal drug
application (NADA) seeking FDA approval to legally market a new
animal drug. The application must include safety and effectiveness
data, proposed labeling, product manufacturing information, and
where necessary, complete information on food safety (including
microbial food safety) and any methods used to determine residues
of drug in edible tissue from food producing animals. FDA Guidance
#152 outlines a risk assessment approach for evaluating the
microbial food safety of antimicrobial new animal drugs. We request
that applicants utilize Form FDA 356V, as appropriate, to ensure
efficient and accurate processing of information to support new
animal drug approval. Respondents may choose to use veterinary
master files to provide and organize confidential detailed
information to the Agency. Veterinary master files can be used as
repositories for information that can be referenced in multiple
submissions to the Agency, thus minimizing paperwork
burden.
Based on a review of the
information collection since our last request for OMB approval, we
have made the following adjustments: In previous submissions of
this ICR we included the time necessary to compile and submit
information to veterinary master files within the burden estimates
provided for applications and amended applications (for NADAs and
INAD files). In this request for OMB extension of approval, we
anticipate respondents’ need for increased use of veterinary master
files and therefore seek approval for such increase. We have
separately estimated the burden of the “Use of veterinary master
files during all phases of product development (including product
development that precedes the establishment of an INAD file or the
submission of an NADA)” in table 1, row 10. We report an additional
300 burden hours and 15 total annual responses in row 10,
representing such increased use of veterinary master files. In
addition, we are also correcting several rounding errors that were
made in our last request for OMB approval. Thus, our estimated
burden for the information collection reflects a net overall
increase of 124 hours and a corresponding increase of 14
responses.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.